facet

  1. T

    Facet Biotech And Bristol-Myers Squibb Report Promising Phase I/II Interim Data For E

    Facet Biotech Corporation (NASDAQ: FACT) and Bristol-Myers Squibb Company (NYSE: BMY) announced that potentially promising data from a Phase I/II study of elotuzumab, an investigational humanized antibody being studied for the treatment of relapsed multiple myeloma (MM), were presented at the...
  2. N

    Facet irritation - 2500 essay?

    How do you write an essay about facet irritation only concentrating on mechanical/ physical disturbances, actual title; "The Pathophysiology of 'Facet Irritation' - The Evidence". I need an idea of what topics to cover and how to layout it out ie intro, middle and conclusion in 2500 words! Any...
Back
Top